HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Use of sapropterin dihydrochloride in maternal phenylketonuria. A European experience of eight cases.

Abstract
Sapropterin dihydrochloride (SD) is the first drug treatment for phenylketonuria (PKU), but due to the lack of data, its use in maternal PKU must be undertaken with caution as noted in the FDA and EMEA labels. We collected data from eight pregnancies in PKU women treated with SD and we analysed the phenotypes of these patients, their tetrahydrobiopterin (BH4) responsiveness, the indications for SD treatment, the efficacy (metabolic control, phenylalanine (Phe) tolerance and offspring outcome) and the safety data. Results showed that in the seven patients known to be responsive to BH4, the use of SD during pregnancy was efficient in terms of metabolic control and Phe tolerance. The indications for giving SD included the failure of the low-Phe diet (n = 3), the fact that some of these women had never experienced the low Phe diet (n = 2), one unexpected pregnancy in a woman currently on SD and one pregnancy where the foetus was known to have PKU. The offspring of these seven pregnancies were all normal babies with normal birth measurements and outcomes. No side effect related to SD was observed in these seven cases. In the eighth case, SD was prescribed as a rescue treatment without previous knowledge of the BH4 responsiveness to a woman who was already 8 weeks pregnant without diet. The birth occurred at 33 weeks of gestational age with Potter syndrome (probably related to the absence of metabolic control during the first trimester) and the baby died in the first hours of life. In conclusion, the data presented here provides the first evidence that treatment with pharmacological doses of SD appears to be efficient and safe in women with PKU during pregnancy. Its use should, however, be restricted to those women previously identified to be clear responders to BH4.
AuthorsFrançois Feillet, Ania C Muntau, François-Guillaume Debray, Amelie S Lotz-Havla, Alexandra Puchwein-Schwepcke, Ma'atem Béatrice Fofou-Caillierez, Francjan van Spronsen, Fritz Friedrich Trefz
JournalJournal of inherited metabolic disease (J Inherit Metab Dis) Vol. 37 Issue 5 Pg. 753-62 (Sep 2014) ISSN: 1573-2665 [Electronic] Netherlands
PMID24789341 (Publication Type: Journal Article)
Chemical References
  • Pterins
  • Biopterin
  • Phenylalanine
  • sapropterin
Topics
  • Adult
  • Biopterin (analogs & derivatives, therapeutic use)
  • Europe
  • Female
  • Fetal Blood (metabolism)
  • Genotype
  • Humans
  • Infant, Newborn
  • Nutritional Status
  • Phenylalanine (blood)
  • Phenylketonuria, Maternal (drug therapy, genetics)
  • Pregnancy
  • Pregnancy Complications (drug therapy)
  • Pregnancy Outcome
  • Pterins (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: